A patient is taking a daily 25 mg prednisone tablet which is 100% bioavailable for the treatment of ulcerative colitis, and his condition is well under control. The patient is to start taking a new prednisone formulation which is known to have bioavailability of 80%. What will be the required dose from this new formulation to control the patient's condition ?